AbbVie Balance Sheet Health
Financial Health criteria checks 3/6
AbbVie has a total shareholder equity of $10.4B and total debt of $59.6B, which brings its debt-to-equity ratio to 573.6%. Its total assets and total liabilities are $134.7B and $124.3B respectively. AbbVie's EBIT is $17.7B making its interest coverage ratio 10.5. It has cash and short-term investments of $12.8B.
Key information
573.6%
Debt to equity ratio
US$59.64b
Debt
Interest coverage ratio | 10.5x |
Cash | US$12.82b |
Equity | US$10.40b |
Total liabilities | US$124.31b |
Total assets | US$134.71b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ABBV *'s short term assets ($33.0B) do not cover its short term liabilities ($37.8B).
Long Term Liabilities: ABBV *'s short term assets ($33.0B) do not cover its long term liabilities ($86.5B).
Debt to Equity History and Analysis
Debt Level: ABBV *'s net debt to equity ratio (450.3%) is considered high.
Reducing Debt: ABBV * had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: ABBV *'s debt is well covered by operating cash flow (38.3%).
Interest Coverage: ABBV *'s interest payments on its debt are well covered by EBIT (10.5x coverage).